Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1983 Nov;48(5):665–673. doi: 10.1038/bjc.1983.248

Correlation between circulating cancer cells and incidence of metastases.

D Glaves
PMCID: PMC2011528  PMID: 6639858

Abstract

Quantitative aspects of the behaviour of B16 melanoma and Lewis lung carcinoma cells during the post-intravasation stages of metastasis were examined in relation to their spontaneous metastatic potential. Cancer cells were isolated from the blood of mice bearing i.m. tumours throughout tumour growth using a novel discontinuous gradient centrifugation technique. Four times more Lewis carcinoma cells than B16 melanoma cells were shed into the circulation, although the numbers of cells shed from either tumour were orders of magnitude more than the numbers of spontaneous pulmonary metastases which developed. Greater numbers of Lewis carcinoma cells were also shed as clumps and with leukocytes attached. However, although similar numbers of radiolabelled melanoma and Lewis carcinoma cells were arrested in the lungs after i.v. injection, fewer carcinoma cells were retained there and 12 times fewer Lewis carcinoma nodules developed in the lungs following injection of non-radiolabelled cells. It appears that the low lung colonization potential of the Lewis lung carcinoma is compensated for during spontaneous metastases by the numbers of cells shed from primary tumours as single cells and as clumps.

Full text

PDF
665

Images in this article

672Figure 3
on p.672

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bishop C. J., Sheridan J. W., Donald K. J. The effect of 125I-5-iodo-2'-deoxyuridine labelling on murine tumour cells. Br J Exp Pathol. 1981 Feb;62(1):22–26. [PMC free article] [PubMed] [Google Scholar]
  2. Butler T. P., Gullino P. M. Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res. 1975 Mar;35(3):512–516. [PubMed] [Google Scholar]
  3. Fidler I. J. Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res. 1975 Jan;35(1):218–224. [PubMed] [Google Scholar]
  4. Fidler I. J., Gersten D. M., Riggs C. W. Relationship of host immune status to tumor cell arrest, distribution, and survival in experimental metastasis. Cancer. 1977 Jul;40(1):46–55. doi: 10.1002/1097-0142(197707)40:1<46::aid-cncr2820400110>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  5. Fidler I. J. Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2'-deoxyuridine. J Natl Cancer Inst. 1970 Oct;45(4):773–782. [PubMed] [Google Scholar]
  6. Fidler I. J. The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. Eur J Cancer. 1973 Mar;9(3):223–227. doi: 10.1016/s0014-2964(73)80022-2. [DOI] [PubMed] [Google Scholar]
  7. Glaves D. Metastasis: reticuloendothelial system and organ retention of disseminated malignant cells. Int J Cancer. 1980 Jul 15;26(1):115–122. doi: 10.1002/ijc.2910260118. [DOI] [PubMed] [Google Scholar]
  8. Hofer K. G., Prensky W., Hughes W. L. Death and metastatic distribution of tumor cells in mice monitored with 125I-iododeoxy-uridine. J Natl Cancer Inst. 1969 Oct;43(4):763–773. [PubMed] [Google Scholar]
  9. James S. E., Salsbury A. J. Facilitation of metastasis by antithymocyte globulin. Cancer Res. 1974 Feb;34(2):367–370. [PubMed] [Google Scholar]
  10. Liotta L. A., Kleinerman J., Saidel G. M. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res. 1974 May;34(5):997–1004. [PubMed] [Google Scholar]
  11. Liotta L. A., Saidel M. G., Kleinerman J. The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res. 1976 Mar;36(3):889–894. [PubMed] [Google Scholar]
  12. MCGREW E. A. CRITERIA FOR THE RECOGNITION OF MALIGNANT CELLS IN CIRCULATING BLOOD. Acta Cytol. 1965 Jan-Feb;9:58–60. [PubMed] [Google Scholar]
  13. Proctor J. W., Mastromatteo W. P., Antos M., Hedderson E. D. Variations in the level of haematogenous antitumour immunity during progressive tumour growth and spontaneous blood-borne metastatic spread. Oncology. 1979;36(2):49–54. doi: 10.1159/000225318. [DOI] [PubMed] [Google Scholar]
  14. Riccardi C., Puccetti P., Santoni A., Herberman R. B. Rapid in vivo assay of mouse natural killer cell activity. J Natl Cancer Inst. 1979 Oct;63(4):1041–1045. [PubMed] [Google Scholar]
  15. Salsbury A. J., Burrage K., Hellmann K. Histological analysis of the antimetastatic effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane. Cancer Res. 1974 Apr;34(4):843–849. [PubMed] [Google Scholar]
  16. Schirrmacher V., Waller C. A. Quantitative determination of disseminated tumor cells by [3H]thymidine incorporation in vitro and by agar colony formation. Cancer Res. 1982 Feb;42(2):660–666. [PubMed] [Google Scholar]
  17. WEISS L. The effects of trypsin on the size, viability and dry mass of sarcoma 37 cells. Exp Cell Res. 1958 Feb;14(1):80–83. doi: 10.1016/0014-4827(58)90214-3. [DOI] [PubMed] [Google Scholar]
  18. Weiss L. Cancer cell traffic from the lungs to the liver: an example of metastatic inefficiency. Int J Cancer. 1980 Mar 15;25(3):385–392. doi: 10.1002/ijc.2910250313. [DOI] [PubMed] [Google Scholar]
  19. Weiss L., Glaves D. The immunospecificity of altered initial arrest patterns of circulating cancer cells in tumor-bearing mice. Int J Cancer. 1976 Dec 15;18(6):774–777. doi: 10.1002/ijc.2910180608. [DOI] [PubMed] [Google Scholar]
  20. Weiss L., Mayhew E., Rapp D. G., Holmes J. C. Metastatic inefficiency in mice bearing B16 melanomas. Br J Cancer. 1982 Jan;45(1):44–53. doi: 10.1038/bjc.1982.6. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES